MA26543A1 - Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles. - Google Patents

Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles.

Info

Publication number
MA26543A1
MA26543A1 MA25243A MA25243A MA26543A1 MA 26543 A1 MA26543 A1 MA 26543A1 MA 25243 A MA25243 A MA 25243A MA 25243 A MA25243 A MA 25243A MA 26543 A1 MA26543 A1 MA 26543A1
Authority
MA
Morocco
Prior art keywords
elastase inhibitors
neutrophilic elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
MA25243A
Other languages
English (en)
French (fr)
Inventor
Geoffrey Duke Edward Clarke
Graham George Adam Inglis
Michael Dennis Dowle
Martin Redpath Johnson
Harry Finch
Simon John Fawcett Macdonald
Lee Andrew Harrison
Pritom Shah
Robin Andrew Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26543A1 publication Critical patent/MA26543A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
MA25243A 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles. MA26543A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds

Publications (1)

Publication Number Publication Date
MA26543A1 true MA26543A1 (fr) 2004-12-20

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25243A MA26543A1 (fr) 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles.

Country Status (24)

Country Link
EP (1) EP1003748A2 (de)
JP (1) JP2001515904A (de)
KR (1) KR20010023766A (de)
CN (1) CN1278820A (de)
AP (1) AP2000001761A0 (de)
AR (1) AR017072A1 (de)
AU (1) AU9741298A (de)
BR (1) BR9812062A (de)
CA (1) CA2303176A1 (de)
CO (1) CO4970719A1 (de)
EA (1) EA200000204A1 (de)
EE (1) EE200000138A (de)
HU (1) HUP0004644A3 (de)
ID (1) ID24452A (de)
IL (1) IL134791A0 (de)
IS (1) IS5391A (de)
MA (1) MA26543A1 (de)
NO (1) NO20001198L (de)
NZ (1) NZ503130A (de)
PE (1) PE107899A1 (de)
PL (1) PL339176A1 (de)
SK (1) SK3192000A3 (de)
TR (1) TR200000907T2 (de)
WO (1) WO1999012933A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
MXPA06011410A (es) 2004-03-31 2007-04-20 Johnson & Johnson Compuestos heterociclicos sin imidazol como moduladores de receptor de histamina h3.
DE102004024772A1 (de) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
JP4853759B2 (ja) * 2004-05-27 2012-01-11 日本農薬株式会社 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
TWI355380B (en) * 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ES2328384T3 (es) 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
DK2024367T3 (da) 2006-05-04 2011-01-03 Pulmagen Therapeutics Inflammation Ltd Tetrahydropyrrolopyrimidindioner og deres anvendelse som inhibitorer af human neutrofil elastase
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
IL125859A0 (en) * 1996-03-28 1999-04-11 Glaxo Group Ltd Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
WO1999012933A2 (en) 1999-03-18
ID24452A (id) 2000-07-20
BR9812062A (pt) 2000-09-26
HUP0004644A3 (en) 2002-01-28
IS5391A (is) 2000-02-29
EE200000138A (et) 2001-02-15
CN1278820A (zh) 2001-01-03
CA2303176A1 (en) 1999-03-18
CO4970719A1 (es) 2000-11-07
EP1003748A2 (de) 2000-05-31
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
NO20001198D0 (no) 2000-03-08
NZ503130A (en) 2001-08-31
NO20001198L (no) 2000-05-08
HUP0004644A2 (hu) 2001-09-28
EA200000204A1 (ru) 2000-10-30
AP2000001761A0 (en) 2000-03-31
IL134791A0 (en) 2001-04-30
TR200000907T2 (tr) 2000-11-21
AR017072A1 (es) 2001-08-22
PL339176A1 (en) 2000-12-04
KR20010023766A (ko) 2001-03-26
AU9741298A (en) 1999-03-29
JP2001515904A (ja) 2001-09-25
PE107899A1 (es) 1999-11-17

Similar Documents

Publication Publication Date Title
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
FR2725204B1 (fr) 2-hydroxyphenyltriazines comme agents photostabilisants
FR07C0057I2 (fr) Derives de pleuromutiline utilises comme agents antimicrobiens
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
NL350032I2 (nl) Pyrazool-4-yl-benzoylderivaten de toepassing ervanals herbiciden
DE69705979D1 (de) Wässrige Besichtungszusammentsetzung
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
MA26544A1 (fr) Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles
EP1046648A4 (de) 3'-desoxyribonukleotid-derivate
EE9800270A (et) Pürasool-4-üülhetaroüülderivaadid herbitsiididena
PT1060183E (pt) Derivados de 5'-desoxicitidina
MA26480A1 (fr) Derives de phenoxymethylpiperidine
ATE372989T1 (de) Azolinderivate
TR28915A (tr) Naftokinon türevleri.
DE59712976D1 (de) Beschichtungsmittel
DK1077984T3 (da) 2'-Deoxyhygromycin derivater
MA26481A1 (fr) Derives d'arylsecocholadiene
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
NO993024D0 (no) Polysakkarid-peptid-derivater
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
IT1295973B1 (it) Procedimento per l'illuminazione di oggetti.